Subscribe to AI For Pharma Growth’s news feed.
Click on “Follow” and decide if you want to get news from AI For Pharma Growth via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to AI For Pharma Growth comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from AI For Pharma Growth which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: AI For Pharma Growth
Is this your feed? Claim it!
In this solo episode of AI For Pharma Growth, Dr Andree Bates explores why many pharma teams do not have an AI problem at all. They have a capability problem.
Dr Andree starts with a simple question: when was your team last properly trained on AI for their specific role? Not when they were given access to tools, licences or a generic use policy, but when they were train...
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nijat Ahmadov, CEO of Nucs AI, about molecular imaging as one of pharma’s most underused data assets.
Nijat explains why PET, CT and other molecular imaging data remain largely “untouched”: clinically valuable and created at scale, but still too often trapped in qualitative reads rather than structured...
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jitesh Halai, founder and CEO of OneSC, about what the Qualified Person role should look like in a more proactive, digitally connected pharmaceutical supply chain.
Jitesh explains how many QPs are still forced into reactive work: chasing documents, checking versions, searching inboxes, reconciling batc...
In this solo episode of AI For Pharma Growth, Dr Andree Bates explains why “we’re doing AI” is not a credible board answer, and why activity, pilots and steering committees are not the same as strategy.
Dr Andree breaks down two common answers leadership teams give when asked about AI strategy.
The episode explores why crowdsourced use cases often become “use cas...
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Bret Bostwick from Breyer Capital about the rare path from genetics, clinical medicine and drug development into venture capital, and what that perspective reveals about the future of healthcare innovation.
Bret shares how the release of the Human Genome Project first pulled him into genetics, and how ...